We exist to improve the lives
of everyone affected by epilepsy

Epilepsy Today Latest News

Event Date: 
Monday 13 March 2017 - 14:57

The US FDA approves cannabidiol medicine Epidiolex for use in Lennox-Gastaut syndrome and Dravet syndrome

28 Jun 2018

On Monday 25 June, the US Food and Drug Administration (FDA) approved the new cannabis-based medicine Epidiolex for use in Lennox-Gastuat syndrome (LGS) and&

Teva lamotrigine tablets – some doses out of stock in the UK

22 Jun 2018

Update 22 June 2018

Lamotrigine Teva 100mg tablets (non-dispersible) have just come back in stock.

The 50mg non-dispersible tablets are still out of stock. Teva does not currently know when these will be back in stock.

Original story 8 June 2018 

Teva is out of stock of the following medicines:

UK government to review use of medicinal cannabis

20 Jun 2018

A review into the use of medicinal cannabis was announced by the Home Office yesterday at the House of Commons.

Home Secretary, Sajid Javid, made the announcement saying that the “position we find ourselves in is not satisfactory”.

Home Office returns confiscated cannabis oil to 12-year-old Northern Ireland boy with epilepsy after he has first seizure in over 300 days

18 Jun 2018

The UK Home Office has returned 12-year-old Billy Caldwell’s cannabis oil epilepsy medicine after he was taken to hospital on Friday 15 June. This was after Billy’s medicine was confiscated at Heathrow Airport on Monday 11 June.

Billy, from Castlederg in Northern Ireland, has a severe form of epilepsy and has previously had up to 100 seizures a day.

Diagnosis, treatment and seeking independence with a Dravet syndrome diagnosis

15 Jun 2018

Maxine has Dravet syndrome, a rare and severe form of epilepsy. Her mum Patricia tells Epilepsy Today about life with the condition, from diagnosis and treatments, to finding independence


Tribunal rules against £89 million government fine issued to Pfizer and Flynn Pharma over price hikes of epilepsy medicines

8 Jun 2018

A UK Competition Appeal Tribunal has overturned the decision to fine two pharmaceutical companies over price hikes of their phenytoin sodium capsules.

Rosemont phenytoin oral suspension discontinued in the UK

21 May 2018

Rosemont has stopped making its version of phenytoin oral suspension.

If you take this version of phenytoin, you’ll need to switch to another manufacturer’s version. If you have any concerns about this, speak to your doctor, epilepsy nurse or pharmacist.

Belfast Trust calls in 2,500 patients for review after consultant neurologist investigation

3 May 2018

The Belfast Trust has called in 2,500 patients for a review after an investigation into the work of a consultant neurologist.

Concerns were raised about Dr Michael Watt’s treatment plans and diagnoses by other doctors. After this, his work was investigated by the trust and the Royal College of Physicians.